Table 2.

Relationship between HCCR1 and HCCR2 expression and clinical features

Clinical characteristics		No. of cases	HCCR1 (×10−3)	P	HCCR2 (×10−3)	P
Age	≤60	52	74.2 ± 45.6	0.290	59.7 ± 47.2	0.079
	>60	28	63.4 ± 39.3		41.2 ± 38.3
Gender	M	48	71.5 ± 38.5	0.647	52.3 ± 33.4	0.668
	F	32	67.1 ± 46.6		48.3 ± 41.7
WBC count (×109)	≤10	27	36.4 ± 25.4	<0.01	21.2 ± 16.5	<0.01
	>10	53	101.8 ± 62.3		79.8 ± 54.8
LDH	Normal	16	65.7 ± 34.1	0.517	44.7 ± 31.5	0.312
	>Normal	64	72.9 ± 40.8		56.2 ± 42.3
CD34 expression	≤20%	43	71.3 ± 38.8	0.637	56.1 ± 47.6	0.238
	>20%	37	67.4 ± 34.2		44.5 ± 38.2
Karyotype	Normal	46	42.7 ± 31.5	<0.01	28.6 ± 23.9	<0.01
	Abnormal	29	94.8 ± 54.6		70.5 ± 59.3

WBC: white blood cell; LDH: lactate dehydrogenase.

The values of HCCR1 and HCCR2 are referring to the relative quantitation of that to GAPDH.